Stemtech (STEK) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Stemtech Corporation  (STEK)


Stemtech's Gross Profit Margin by quarter

Trends, Rankings, Statistics



STEK Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -9.83 %
Seq. Revenue Change 35.93 %
Revenue In Millions $0.63
Gross Profit Margin 74 %
Gross Profit Margin Total Ranking # 767
Gross Profit In Millions $0.47
Y / Y Gross Profit Change -15.64 %
Seq. Gross Profit Change 31.66 %


Commenting Second Quarter 2026 Gross Profit Margin
Stemtech has managed to improve its Revenue sequentially to $0.63 millions by 35.93 % faster than Gross Profit increase of 31.66 % to $0.47 millions, this led to contraction in Gross Profit Margin to 74 %, but the Stemtech II. Quarter Gross Profit Margin remained above company average rate of 72.23%.


Observing second quarter 2026 results within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 631 to 767.
Learn about Gross Margin
STEK's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 3
Retail Sector # 7
Overall # 761

Gross Profit Margin Statistics
High Average Low
86.07 % 72.23 % 19.62 %
(Sep 30 2021)   (Dec 31 2022)




Other Gross Profit Margin Profitability Ratios
STEK's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
STEK's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for STEK's Competitors
Gross Profit Margin Profit Margin for Stemtech's Suppliers
Gross Profit Margin Profit Margin for STEK's Customers

You may also want to know
STEK's Annual Growth Rates STEK's Profitability Ratios STEK's Asset Turnover Ratio STEK's Dividend Growth
STEK's Roe STEK's Valuation Ratios STEK's Financial Strength Ratios STEK's Gross Profit Growth
STEK's Roa STEK's Inventory Turnover Ratio STEK's Growth Rates STEK's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Herbalife Ltd   77.67 %$ 1,030.500  Millions$ 1,326.800  Millions
Stemtech Corporation  74.00 %$ 0.466  Millions$ 0.629  Millions
Nu Skin Enterprises Inc   68.20 %$ 218.325  Millions$ 320.112  Millions
Cvs Health Corporation  44.52 %$ 47,234.000  Millions$ 106,096.000  Millions
Hwh International Inc   31.72 %$ 0.020  Millions$ 0.064  Millions
Petmed Express Inc   27.63 %$ 11.333  Millions$ 41.015  Millions
Guardian Pharmacy Services Inc   22.75 %$ 80.044  Millions$ 351.768  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.